Generics And Patent Strategies Returns For Its 16th Year, 13-14 May 2013, London

news headlines

email to a friend

printer friendly

Generics And Patent Strategies Returns For Its 16th Year, 13-14 May 2013, London

Main Category: Conferences

Article Date: 15 Mar 2013

The respected Generics and Patent Strategies event will be returning for the 16th Instalment on 13th & 14th May, London. SMi's event promises to bring together world-renowned experts to present the hottest topics and key challenges faced within the Generics industry today.

The established conference is well known in the Generic Drug Patents industry and has always had good reviews:

"Good Presentations on Important topics" - Abbott
"Very interesting meeting" - Boehringer-Ingelheim

 With presentations and interactive panel discussions, the event will provide attendees with the latest updates on increasing profitability in a highly competitive market, how to overcome some of the IP issues faced when challenging patents and a detailed look at the pricing pressures surrounding an already saturated marketplace.

Speakers Presenting Will Include:
Bernd Stoiber, Head of Global Generics, AstraZeneca
 Rahul Garella, Senior Vice President - EU Business, Glenmark
 Paul Csiszar, Director Basic Industries, Manufacturing and Agriculture, European Commission 
Julie Barrett-Major, Director of IP, Norgine 
Cheetak Buaria, Director, Alliance Manager, Merck Serono

Visit http://www.smi-online.co.uk/goto/pharma-generics15.asp. Alternatively contact Jonathan Collins on tel: +44 (0) 20 7827 6734 or email: jcollins@smi-online.co.uk

Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today

Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles.

< back to medical news

For any corrections of factual information, or to contact the editors please use our feedback form.

Send your press releases to